Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients.

Tae Hwan MoonGwon Hui JoEoi Jong SeoKyung Tae KimEu Jeong KuSoon Kil KwonJin Young KimJu Byung ChaeDong Yoon Kim

Published in: Journal of clinical medicine (2022)

From this preliminary study, we observed that renal function might affect the response to IVBI treatment in patients with DME. In the case of a poor response to initial IVBI treatment for DME in patients with moderate to severe CKD, our study supports switching to the aflibercept or dexamethasone implant.

Keyphrases

end stage renal disease
chronic kidney disease
low dose
newly diagnosed
high dose
ejection fraction
replacement therapy
soft tissue
drug induced